We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Albemarle (ALB) Stock Slides as Market Rises: Facts to Know Before You Trade
Read MoreHide Full Article
Albemarle (ALB - Free Report) ended the recent trading session at $114.85, demonstrating a -1.76% change from the preceding day's closing price. This change lagged the S&P 500's 0.05% gain on the day. Elsewhere, the Dow saw an upswing of 0.46%, while the tech-heavy Nasdaq depreciated by 0.64%.
Coming into today, shares of the specialty chemicals company had lost 17.11% in the past month. In that same time, the Basic Materials sector lost 1.68%, while the S&P 500 gained 0.61%.
The investment community will be closely monitoring the performance of Albemarle in its forthcoming earnings report. The company is scheduled to release its earnings on August 5, 2026. The company is expected to report EPS of $3.39, up 2981.82% from the prior-year quarter. At the same time, our most recent consensus estimate is projecting a revenue of $1.53 billion, reflecting a 15.04% rise from the equivalent quarter last year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $12.86 per share and a revenue of $6.11 billion, signifying shifts of +1727.85% and +18.87%, respectively, from the last year.
Investors should also pay attention to any latest changes in analyst estimates for Albemarle. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.94% downward. As of now, Albemarle holds a Zacks Rank of #3 (Hold).
With respect to valuation, Albemarle is currently being traded at a Forward P/E ratio of 9.09. This signifies a discount in comparison to the average Forward P/E of 14.87 for its industry.
The Chemical - Diversified industry is part of the Basic Materials sector. This industry, currently bearing a Zacks Industry Rank of 91, finds itself in the top 37% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Albemarle (ALB) Stock Slides as Market Rises: Facts to Know Before You Trade
Albemarle (ALB - Free Report) ended the recent trading session at $114.85, demonstrating a -1.76% change from the preceding day's closing price. This change lagged the S&P 500's 0.05% gain on the day. Elsewhere, the Dow saw an upswing of 0.46%, while the tech-heavy Nasdaq depreciated by 0.64%.
Coming into today, shares of the specialty chemicals company had lost 17.11% in the past month. In that same time, the Basic Materials sector lost 1.68%, while the S&P 500 gained 0.61%.
The investment community will be closely monitoring the performance of Albemarle in its forthcoming earnings report. The company is scheduled to release its earnings on August 5, 2026. The company is expected to report EPS of $3.39, up 2981.82% from the prior-year quarter. At the same time, our most recent consensus estimate is projecting a revenue of $1.53 billion, reflecting a 15.04% rise from the equivalent quarter last year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $12.86 per share and a revenue of $6.11 billion, signifying shifts of +1727.85% and +18.87%, respectively, from the last year.
Investors should also pay attention to any latest changes in analyst estimates for Albemarle. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.94% downward. As of now, Albemarle holds a Zacks Rank of #3 (Hold).
With respect to valuation, Albemarle is currently being traded at a Forward P/E ratio of 9.09. This signifies a discount in comparison to the average Forward P/E of 14.87 for its industry.
The Chemical - Diversified industry is part of the Basic Materials sector. This industry, currently bearing a Zacks Industry Rank of 91, finds itself in the top 37% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.